Equities Analysts Issue Forecasts for Senestech Q3 Earnings

Senestech, Inc. (NASDAQ:SNES) – Equities researchers at Zacks Research boosted their Q3 2026 earnings per share (EPS) estimates for shares of Senestech in a report issued on Thursday, October 22nd. Zacks Research analyst M. Marin now expects that the company will post earnings per share of ($0.31) for the quarter, up from their previous forecast of ($0.34). The consensus estimate for Senestech’s current full-year earnings is ($1.28) per share. Zacks Research also issued estimates for Senestech’s Q4 2026 earnings at ($0.30) EPS, FY2026 earnings at ($1.26) EPS and FY2027 earnings at ($0.98) EPS.

Separately, Weiss Ratings cut Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, August 11th. One analyst has rated the stock with a Sell rating. According to MarketBeat, Senestech presently has an average rating of “Sell”.

Senestech Price Performance

NASDAQ SNES opened at $0.84 on Wednesday. Senestech has a 12-month low of $0.55 and a 12-month high of $3.70. The firm has a 50-day moving average price of $0.87 and a two-hundred day moving average price of $1.51.

Senestech (NASDAQ:SNES) last posted its earnings results on Wednesday, August 5th. The company reported ($0.35) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.02. The company had revenue of $0.77 million for the quarter, compared to analyst estimates of $0.60 million.

Institutional Trading of Senestech

An institutional investor recently bought a new stake in Senestech stock. Diversify Wealth Management LLC bought a new position in Senestech, Inc. (NASDAQ:SNES) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 19,119 shares of the company’s stock, valued at approximately $31,000. Diversify Wealth Management LLC owned about 0.36% of Senestech at the end of the most recent quarter. Institutional investors own 5.19% of the company’s stock.

Insider Activity

In other Senestech news, major shareholder Glenbrook Capital Management purchased 426,000 shares of the stock in a transaction dated Thursday, October 15th. The stock was bought at an average price of $0.77 per share, with a total value of $328,020.00. Following the acquisition, the insider owned 1,505,294 shares of the company’s stock, valued at approximately $1,159,076.38. This represents a 39.47% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. In the last 90 days, insiders acquired 1,115,169 shares of company stock valued at $813,573. Company insiders own 2.20% of the company’s stock.

About Senestech

SenesTech, Inc is a biotechnology company focused on developing fertility-control technologies for managing animal populations. The company’s approach is designed to reduce reproduction rather than rely solely on lethal control methods, with applications primarily in rodent management.

SenesTech’s principal product is ContraPest, a liquid bait designed to reduce fertility in rats by affecting reproductive function in both male and female animals. The product is intended for use in commercial, municipal and other settings where rat populations pose sanitation, health or property risks.